The Baylor College of Medicine has named Matthew Ellis the newest McNair Scholar, a program that identifies researchers in breast and pancreatic cancer, juvenile diabetes, and neuroscience.
Ellis joined Baylor in September to serve as director of the Lester and Sue Smith Breast Center. He is also a funded scholar of the Cancer Prevention and Research Institute of Texas and the Susan G. Komen Foundation for the Cure and serves as a professor of medicine and member of the National Cancer Institute-designated Dan L. Duncan Cancer Center at Baylor. Prior to joining Baylor, Ellis served as professor of medicine, head of breast oncology, and head of medical oncology at Washington University School of Medicine. He was also previously on the faculty at Duke University and Georgetown University.
Vanderbilt University has appointed Nancy Cox the founding director of the new Vanderbilt Genetics Institute, effective Jan. 1, 2015. She also will be a professor of genetics and direct the division of genetic medicine in the department of medicine.
Cox is currently a professor of medicine and human genetics and the chief of the section of genetic medicine at the University of Chicago. She received her Ph.D. in human genetics from Yale University.
Pathway Genomics has appointed Glenn Braunstein to its medical advisory board. He is currently the vice president of clinical innovation, director of the Thyroid Cancer Center, and professor of medicine at Cedars-Sinai. He also has served for 26 years as chair of the department of medicine at Cedars-Sinai.
Premaitha Health as appointed Yves Derveaux as regional European sales consultant for Southern Europe as the company prepares to launch its non-invasive prenatal test, Iona. Before joining Premaitha Health, Derveaux was country manager of France and sales of Southern Europe for Epigenomics and country manager of France and Switzerland at Agendia. Derveaux will report to Premaitha Health’s COO Peter Collins.